Organogenesis Q3 EPS $0.02, Net Revenue $108.5M vs $111.4M Est.
Portfolio Pulse from Benzinga Newsdesk
Organogenesis has reported its Q3 earnings per share (EPS) at $0.02, with net revenue of $108.5M, which is lower than the estimated $111.4M.
November 09, 2023 | 9:48 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Organogenesis' Q3 earnings report shows lower than expected net revenue, which could negatively impact the company's stock price.
Organogenesis' Q3 net revenue was lower than estimated. This underperformance could lead to a decrease in investor confidence, potentially driving the stock price down in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100